SCHEMBL7345745

SCHEMBL7345745

CCCCCCOc1ccc(S(=O)(=O)N(CC(=O)OCC)CC(C)C)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 7/20 0.73
MMP2 P08253 3/20 0.47
MMP13 P45452 2/20 0.47
MMP14 P50281 2/20 0.47
ADAMTS4 O75173 1/20 0.47
ADAMTS5 Q9UNA0 1/20 0.47
MMP9 P14780 2/20 0.47
MMP1 P03956 1/20 0.47
MMP8 P22894 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TAS2R14 Q9NYV8 1/20 0.44
GAA P10253 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
LTA4H P09960 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343349 0.84 MMP3 (1.00) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL7350659 0.84 MMP3 (1.00) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL7342014 0.83 ALDH1A1 (0.64) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL7339459 0.81 KMT2A (0.54) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL7341391 0.81 MMP3 (1.00) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL26770275 0.76 MMP3 (0.91) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL2518752 0.76 GAA (0.47) MMP3MMP2MMP13MMP14MMP9
SCHEMBL6324386 0.75 MMP3 (0.60) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL22329142 0.74 MMP3 (0.54) MMP3MMP2MMP13MMP14ADAMTS4
SCHEMBL6322271 0.74 MMP3 (0.59) MMP3MMP2MMP13MMP14ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606046-B1 Arylsulfonamido-substituted hydroxamic acids CIBA GEIGY AG (CH) 1997-10-08 EP disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
US-5552419-A METALLOPROTEINASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-09-03 US disclosed
US-5506242-A METALLOELASTASE INHIBITOR; TREATS EMPHYSEMA CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
US-5455258-A Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase CIBA-GEIGY CORPORATION (US) 1995-10-03 US disclosed
EP-0606046-A1 Arylsulfonamido-substituted hydroxamic acids CIBA-GEIGY AG (CH) 1994-07-13 EP disclosed